# The Misuse of Drugs Regulations 2001, Paragraph 10


A liquid formulation—
(a) containing cannabidiol obtained by extraction and purification from cannabis;
(b) where the concentration of—
(i) delta-9-tetrahydrocannabinol is not more than 0.1 milligram per millilitre; and
(ii) cannabidiol is 95-105 milligrams per millilitre;
(c) which is presented in a bottle, as an oral solution for oral administration; and
(d) which was approved for marketing by the European Commission on 19th September 2019.

---
Source: https://www.legislation.gov.uk/uksi/2001/3998/schedule/5/paragraph/10 (the official version)
Page: https://openlegislation.uk/misuse-of-drugs-regulations-2001/schedule-5/paragraph-10
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.